nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Advances of neuroimaging in chemotherapy related cognitive impairment (CRCI) of patients with breast cancer
|
Yao, Senbang |
|
|
201 |
1 |
p. 15-26 |
artikel |
2 |
Conventional specimen radiography in breast-conserving therapy: a useful tool for intraoperative margin assessment after neoadjuvant therapy?
|
Schäfgen, Benedikt |
|
|
201 |
1 |
p. 57-66 |
artikel |
3 |
Development of cardiometabolic risk factors following endocrine therapy in women with breast cancer
|
Rillamas-Sun, Eileen |
|
|
201 |
1 |
p. 117-126 |
artikel |
4 |
Heterogeneous circulating tumor cells correlate with responses to neoadjuvant chemotherapy and prognosis in patients with locally advanced breast cancer
|
Ma, Ge |
|
|
201 |
1 |
p. 27-41 |
artikel |
5 |
Identifying miRNA biomarkers for breast cancer and ovarian cancer: a text mining perspective
|
Li, Xin |
|
|
201 |
1 |
p. 5-14 |
artikel |
6 |
Impact of non-adherence to endocrine therapy on recurrence risk in older women with stage I breast cancer after breast-conserving surgery
|
Rodin, Danielle |
|
|
201 |
1 |
p. 77-87 |
artikel |
7 |
Is there any association between declined creatinine clearence and higher endoxifen levels in older patients with non-metastatic breast cancer?
|
Altundag, Kadri |
|
|
201 |
1 |
p. 147 |
artikel |
8 |
It is the impact of racism, not race, that causes breast cancer inequities
|
Rollin, Francois G. |
|
|
201 |
1 |
p. 149-150 |
artikel |
9 |
Modeling the novel SERD elacestrant in cultured fulvestrant-refractory HR-positive breast circulating tumor cells
|
Dubash, Taronish D. |
|
|
201 |
1 |
p. 43-56 |
artikel |
10 |
No more disparities among regions in Italy: recent approval of genomic test reimbursability for early breast cancer patients in the country
|
Bravaccini, Sara |
|
|
201 |
1 |
p. 1-3 |
artikel |
11 |
Radiofrequency localization of nonpalpable breast cancer in a multicentre prospective cohort study: feasibility, clinical acceptability, and safety
|
Christenhusz, Anke |
|
|
201 |
1 |
p. 67-75 |
artikel |
12 |
Survival benefits associated with being adherent and having longer persistence to adjuvant hormone therapy across up to five years among U.S. Medicare population with breast cancer
|
Zheng, Dandan |
|
|
201 |
1 |
p. 89-104 |
artikel |
13 |
Surviving the COVID-19 pandemic: navigating the recovery of breast imaging services in a safety-net hospital
|
Porembka, Jessica H. |
|
|
201 |
1 |
p. 127-138 |
artikel |
14 |
Treatment patterns and outcomes associated with sequential and non-sequential use of CDK4 & 6 inhibitors in patients with HR+, HER2− MBC in the real world
|
Kruse, Megan |
|
|
201 |
1 |
p. 105-115 |
artikel |
15 |
Validating the PROMIS cognitive function short form in cancer survivors
|
Henneghan, Ashley M. |
|
|
201 |
1 |
p. 139-145 |
artikel |